Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Igor Y. Vinogradov"'
Autor:
Vladimir O. Sigin, Alexey I. Kalinkin, Alexandra F. Nikolaeva, Ekaterina O. Ignatova, Ekaterina B. Kuznetsova, Galina G. Chesnokova, Nikolai V. Litviakov, Matvey M. Tsyganov, Marina K. Ibragimova, Ilya I. Vinogradov, Maxim I. Vinogradov, Igor Y. Vinogradov, Dmitry V. Zaletaev, Marina V. Nemtsova, Sergey I. Kutsev, Alexander S. Tanas, Vladimir V. Strelnikov
Publikováno v:
Cancers; Volume 15; Issue 5; Pages: 1630
Despite advances in the diagnosis and treatment of breast cancer (BC), the main cause of deaths is resistance to existing therapies. An approach to improve the effectiveness of therapy in patients with aggressive BC subtypes is neoadjuvant chemothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22ef7f03d73ecf4dc38b00694b2b83ab
https://doi.org/10.3390/cancers15051630
https://doi.org/10.3390/cancers15051630
Autor:
Igor Y. Vinogradov, Maksim I. Vinogradov, Matvey M. Tsyganov, Dmitry V. Zaletaev, Olga A Simonova, Alexander S Tanas, Ekaterina B. Kuznetsova, Vladimir O. Sigin, Ilya I. Vinogradov, Sergey I. Kutsev, Ilya V. Volodin, A.I. Kalinkin, Galina G. Chesnokova, Elena M. Slonimskaya, Nikolai V. Litviakov, Vladimir V Strelnikov, M.K. Ibragimova
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports
Scientific Reports
Despite the advantages of neoadjuvant chemotherapy (NACT), associated toxicity is a serious complication that renders monitoring of the patients’ response to NACT highly important. Thus, prediction of tumor response to treatment is imperative to av
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c8128c9c63b7dcc79fd41a80a9b4f54
http://link.springer.com/article/10.1038/s41598-020-66197-1
http://link.springer.com/article/10.1038/s41598-020-66197-1